- Home
- COLL vs SBH Comparison
COLL vs SBH Comparison
Compare COLL & SBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLL | SBH |
|---|---|---|
| Founded | 2002 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2015 | 2006 |
Fundamental Metrics
Financial Performance| Metric | COLL | SBH |
|---|---|---|
| Price | $34.50 | $14.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $50.83 | $17.25 |
| AVG Volume (30 Days) | 400.6K | ★ 1.3M |
| Earning Date | 05-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.17 |
| EPS | ★ 1.73 | 0.45 |
| Revenue | $780,567,000.00 | ★ $3,701,424,000.00 |
| Revenue This Year | $6.07 | $2.20 |
| Revenue Next Year | N/A | $1.82 |
| P/E Ratio | ★ $20.21 | $31.99 |
| Revenue Growth | ★ 23.62 | N/A |
| 52 Week Low | $23.23 | $7.54 |
| 52 Week High | $50.79 | $17.92 |
Technical Indicators
Market Signals| Indicator | COLL | SBH |
|---|---|---|
| Relative Strength Index (RSI) | 16.51 | 40.08 |
| Support Level | $34.30 | $14.10 |
| Resistance Level | $36.20 | $15.75 |
| Average True Range (ATR) | 1.59 | 0.54 |
| MACD | -0.70 | -0.16 |
| Stochastic Oscillator | 2.18 | 15.07 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.